FAKTOR-OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 18:13:01 06/06/2024 BST | ||
| 9.97 EUR | +0.91% |
|
| Current month | +1.44% | ||
| 1 month | +1.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 9.97 | +0.91% |
| 05/06/24 | 9.88 | -0.80% |
| 04/06/24 | 9.96 | -1.19% |
| 03/06/24 | 10.08 | +3.49% |
| 31/05/24 | 9.74 | -3.75% |
Delayed Quote Deutsche Boerse AG
Last update June 06, 2024 at 06:13 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV12D6 |
| ISIN | DE000SV12D63 |
| Date issued | 15/03/2023 |
| Strike | 76.77 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.01 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.74 € |
|---|---|
| Lowest since issue | 5.46 € |
| Spread | 0.03 € |
| Spread % | 0.30% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.07
USD
Average target price
96.31
USD
Spread / Average Target
+10.61%
- Stock Market
- Certificates
- Certificat
